Xiaoling Xu

19.3k citations
191 papers · 12.9k · 5 hit papers · h-index 47

Impact in

    • Sirtuins and Resveratrol in Medicine
    • DNA Repair Mechanisms
    • CRISPR and Genetic Engineering
    • TGF-β signaling in diseases
    • Epigenetics and DNA Methylation
    • Fibroblast Growth Factor Research

Papers in

    • DNA Repair Mechanisms 16
    • Epigenetics and DNA Methylation 14
    • CRISPR and Genetic Engineering 11
    • Cancer-related Molecular Pathways 11

Xiaoling Xu

184 papers receiving 12.7k citations

Xiaoling Xu's Hit Papers

Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice 2018 · 628 citations
6280+9+18Years since publication200400600

Peers

Xiaoling Xu
Comparison fields: 5 of 180
  • Geriatrics and Gerontology 1.6k
  • Molecular Biology 7.3k
  • Aging 168
  • Cancer Research 1.2k
  • Genetics 2.4k
Replace Leif W. Ellisen with:
Leif W. Ellisen United States
Xin Wei Wang United States
Tong‐Chuan He United States
Chenguang Wang China
Hanina Hibshoosh United States
Govind Bhagat United States
Siraj M. Ali United States
Gautam Bandyopadhyay United States
Esteban Ballestar Spain
Masashi Narita United Kingdom
Xiaoling Xu relative to Leif W. Ellisen United States Leif W. Ellisen's profile →
Citations per field
00.5×3.0×
Leif W. Ellisen · 1×
Citations per year

Countries citing papers authored by Xiaoling Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Xu more than expected).

Fields of papers citing papers by Xiaoling Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Xu. The network helps show where Xiaoling Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoling Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoling Xu Line = papers co-authored together Xiaoling Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Centrosome Amplification and a Defective G2–M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform–Deficient Cells
Hit paper breakdown →
1999667
2
Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
Hit paper breakdown →
2008638
3
Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice
Hit paper breakdown →
2018628
4
Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
Hit paper breakdown →
1999599
5
TGF-β/Smad3 Signals Repress Chondrocyte Hypertrophic Differentiation and Are Required for Maintaining Articular Cartilage
Hit paper breakdown →
2001539
6 2005498
7 2004459
8 1998457
9 2011422
10 2010413
11 1998371
12 2004326
13 1999325
14 1998300
15 2001296
16 2008284
17 1998274
18 2011261
19 1998254
20 2000183

About Xiaoling Xu

Xiaoling Xu is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Pulmonary and Respiratory Medicine, having authored 191 papers that have together received 12.9k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (16 papers), BRCA gene mutations in cancer (16 papers), Sirtuins and Resveratrol in Medicine (16 papers), Epigenetics and DNA Methylation (14 papers), Cancer Genomics and Diagnostics (11 papers), Cancer-related Molecular Pathways (11 papers), CRISPR and Genetic Engineering (11 papers) and Adipose Tissue and Metabolism (9 papers). The work is most often cited by research in Geriatrics and Gerontology (1.6k citations), Molecular Biology (7.3k citations), Aging (168 citations), Cancer Research (1.2k citations) and Genetics (2.4k citations). Xiaoling Xu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Chu‐Xia Deng, Xiao Yang, Michael Weinstein, Cuiling Li, Cuiying Xiao, Rui-Hong Wang, Cuiling Li, Hyun‐Seok Kim, Cuiling Li and Thomas Ried. Their work appears in journals such as Oncogene, International Journal of Biological Sciences, Development, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact